Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine

British Journal of Haematology

Volumn 158, Issue 2, 2012, Pages 286-288

  Jamroziak, Krzysztof ^a   Grzybowska Izydorczyk, Olga ^a   Jesionek Kupnicka, Dorota ^a   Gora Tybor, Joanna ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Chronic lymphocytic leukemia; Cladribine; Fludarabine; Hodgkin lymphoma; Richter transformation

Indexed keywords

BLEOMYCIN; CLADRIBINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; PURINE NUCLEOSIDE DERIVATIVE; RITUXIMAB; VINBLASTINE; VINCRISTINE SULFATE;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DIFFUSE LARGE B CELL LYMPHOMA RICHTER TRANSFORMATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HODGKIN DISEASE; HODGKIN RICHTER TRANSFORMATION; HUMAN; LARGE CELL LYMPHOMA; LETTER; LEUKEMIA REMISSION; MALE; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;

EID: 84863460801     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09127.x     Document Type: Letter

References (10)

1. Bockorny, B., Codreanu, I. & Dasanu, C.A. (2012) Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. British Journal of Haematology, 156, 50-66.
2. Brecher, M. & Banks, P.M. (1990) Hodgkin's disease variant of Richter's syndrome. Report of eight cases. American Journal of Clinical Pathology, 93, 333-339.
3. Karlsson, K., Strömberg, M., Liliemark, J., Delannoy, A., Johnson, S.A., Porwit, A., Kimby, E., Lärfars, G., Cristiansen, I., Nilsson, G., Celsing, F., Sundström, G., Luthman, M., Tidefelt, U., Wallvik, J. & Juliusson, G. (2002) Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients. British Journal of Haematology, 116, 538-548.
4. Kay, N.E., Wu, W., Kabat, B., LaPlant, B., Lin, T.S., Byrd, J.C., Jelinek, D.F., Grever, M.R., Zent, C.S., Call, T.G. & Shanafelt, T.D. (2010) Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia. Cancer, 116, 2180-2187.
5. Molica, S.A. (2010) Systematic review on Richter syndrome: what is the published evidence? Leukemia & Lymphoma, 51, 415-421.
6. Robak, T., Szmigielska-Kaplon, A., Smolewski, P., Wawrzyniak, E., Korycka, A., Bartkowiak, J. & Kordek, R. (2003) Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. Leukemia & Lymphoma, 44, 859-866.
7. Robak, T., Blonski, J.Z., Gora-Tybor, J., Jamroziak, K., Dwilewicz-Trojaczek, J., Tomaszewska, A., Konopka, L., Ceglarek, B., Dmoszynska, A., Kowal, M., Kloczko, J., Stella-Holowiecka, B., Sulek, K., Calbecka, M., Zawilska, K., Kuliczkowski, K., Skotnicki, A.B., Warzocha, K., Kasznicki, M. & Polish Leukemia Group (PALG CLL2) (2006) Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2). Blood, 108, 473-479.
8. Serratrice De Roux, C., Coso, D., Bouabdallah, R., Serratrice, J., Disdier, P. & Weiller, P.J. (2000) Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis. Haematologica, 85, 878-879.
9. Tsimberidou, A.M., O'Brien, S., Kantarjian, H.M., Koller, C., Hagemeister, F.B., Fayad, L., Lerner, S., Bueso-Ramos, C.E. & Keating, M.J. (2006) Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience. Cancer, 107, 1294-1302.
10. Younes, A., Bartlett, N.L., Leonard, J.P., Kennedy, D.A., Lynch, C.M., Sievers, E.L. & Forero-Torres, A. (2010) Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas. New England Journal of Medicine, 363, 1812-1821.